[HTML][HTML] The potential of high-anthocyanin purple rice as a functional ingredient in human health

S Yamuangmorn, C Prom-u-Thai - Antioxidants, 2021 - mdpi.com
Purple rice is recognized as a source of natural anthocyanin compounds among
healthconscious consumers who employ rice as their staple food. Anthocyanin is one of the …

Methodology-centered review of molecular modeling, simulation, and prediction of SARS-CoV-2

K Gao, R Wang, J Chen, L Cheng, J Frishcosy… - Chemical …, 2022 - ACS Publications
Despite tremendous efforts in the past two years, our understanding of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), virus–host interactions, immune …

Effects of shading at different growth stages with various shading intensities on the grain yield and anthocyanin content of colored rice (Oryza sativa L.)

S Song, A He, T Zhao, Q Yin, Y Mu, Y Wang, H Liu… - Field Crops …, 2022 - Elsevier
Colored rice is a high-quality and high-added-value rice that has attracted increasing
attention in recent years. Therein, the main functional substance in colored rice is …

Natural products for the prevention and control of the COVID-19 pandemic: sustainable bioresources

RK Singla, X He, H Chopra, C Tsagkaris… - Frontiers in …, 2021 - frontiersin.org
Background: The world has been unprecedentedly hit by a global pandemic which broke the
record of deadly pandemics that faced humanity ever since its existence. Even kids are well …

Natural products-based drug design against SARS-CoV-2 Mpro 3CLpro

RC Silva, HF Freitas, JM Campos, NM Kimani… - International journal of …, 2021 - mdpi.com
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), has received global attention due to the serious threat it poses …

Recent advances towards natural plants as potential inhibitors of SARS-Cov-2 targets

Z He, J Yuan, Y Zhang, R Li, M Mo, Y Wang… - Pharmaceutical …, 2023 - Taylor & Francis
Abstract Context Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), is still ongoing and currently the most striking …

[HTML][HTML] An overview of potential inhibitors targeting non-structural proteins 3 (PLpro and Mac1) and 5 (3CLpro/Mpro) of SARS-CoV-2

F Yan, F Gao - Computational and structural biotechnology journal, 2021 - Elsevier
There is an urgent need to develop effective treatments for coronavirus disease 2019
(COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS …

Structure-based identification of potential SARS-CoV-2 main protease inhibitors

S Khan, Z Fakhar, A Hussain, A Ahmad… - Journal of …, 2022 - Taylor & Francis
To address coronavirus disease (COVID-19), currently, no effective drug or vaccine is
available. In this regard, molecular modeling approaches are highly useful to discover …

Pharmacogenetics and precision medicine approaches for the improvement of COVID-19 therapies

M Biswas, N Sawajan, T Rungrotmongkol… - Frontiers in …, 2022 - frontiersin.org
Many drugs are being administered to tackle coronavirus disease 2019 (COVID-19)
pandemic situations without establishing clinical effectiveness or tailoring safety. A …

ABBV-744 as a potential inhibitor of SARS-CoV-2 main protease enzyme against COVID-19

Z Fakhar, S Khan, SY AlOmar, A Alkhuriji, A Ahmad - Scientific reports, 2021 - nature.com
A new pathogen severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
spread worldwide and become pandemic with thousands new deaths and infected cases …